The Impact of FDA’s New Ruling on Laboratory Billing

The FDA’s new ruling on LDTs is critical in regulating laboratory-developed diagnostic products. Understanding the implications of the ruling for medical billing practices is important. We can successfully navigate this evolving regulatory landscape by proactively adapting billing processes, prioritizing regulatory compliance, and advocating for patient-centric care. Here are some of the implications of the new […]

How the New FDA Ruling Will Effect Lab-Developed Tests

A long-awaited decision by the Food and Drug Administration (FDA) that went into effect in April 2024 aims to standardize the regulatory framework for laboratory-developed tests (LDTs), ensuring patient safety and test effectiveness. Here are some examples of how this ruling will affect healthcare providers and laboratories in the coming years. Understanding Laboratory-Developed Tests Laboratory-developed […]